The life cycle of the endocannabinoids: Formation and inactivation

Current Topics in Behavioral Neurosciences

Volumn 1, Issue , 2009, Pages 3-35

  Alexander, Stephen P H ^a   Kendall, David A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

2 arachidonoylglycerol; Anandamide; Diacylglcyerol lipase; Endocannabinoid turnover; Fatty acid amide hydrolase; N acylphosphatidylethanolamine phospholipase D

Indexed keywords

CANNABINOID RECEPTOR; CARBOXYLESTERASE; ENDOCANNABINOID;

ANIMAL; ARTICLE; CENTRAL NERVOUS SYSTEM; CHEMISTRY; DRUG EFFECT; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CARBOXYLIC ESTER HYDROLASES; CENTRAL NERVOUS SYSTEM; ENDOCANNABINOIDS; HUMANS; RECEPTORS, CANNABINOID; SIGNAL TRANSDUCTION;

EID: 79952114783     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/978-3-540-88955-7_1     Document Type: Article

References (163)

1. Ahn DK, Choi HS, Yeo SP et al. (2007) Blockade of central cyclooxygenase (COX) pathways enhances the cannabinoid-induced antinociceptive effects on inflammatory temporomandibular joint (TMJ) nociception. Pain 132:23-32
2. Aneetha H, O'Dell DK, Tan B et al. (2009) Alcohol dehydrogenase-catalyzed in vitro oxidation of anandamide to N-arachidonoyl glycine, a lipid mediator: Synthesis of N-acyl glycinals. Bioorg Med Chem Lett 19:237-241
3. 1belonging to the pancreatic lipase gene family. Biochimie 89:197-204
4. Artmann A, Petersen G, Hellgren LI et al. (2008) Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta-Mol Cell Biol L 1781:200-212
5. Bajo M, Roberto M, Schweitzer P (2009) Differential alteration of hippocampal excitatory synaptic transmission by cannabinoid ligands. J Neurosci Res 87:766-775
6. Basanez G, Nieva JL, Goni FM et al. (1996) Origin of the lag period in the phospholipase C cleavage of phospholipids in membranes. Concomitant vesicle aggregation and enzyme activation. Biochemistry 35:15183-15187
7. Bequet F, Uzabiaga F, Desbazeille Met al. (2007) CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus. Eur J Neurosci 26:3458-3464
8. Berdyshev EV, Schmid PC, Krebsbach RJ et al. (2001) Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. FASEB J 15:2171-2178
9. Bisogno T, Maurelli S, Melck D et al. (1997) Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. J Biol Chem 272:3315-3323
10. Bisogno T, Melck D, De Petrocellis L et al. (1999) Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin. J Neurochem 72:2113-2119
11. Bisogno T, Howell F, Williams G et al. (2003) Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163:463-468
12. Bisogno T, Ortar G, Petrosino S et al. (2009) Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo. Biochim Biophys Acta 1791:53-60
13. Bobrov MY, Shevchenko VP, Yudushkin IA et al. (2000) Hydrolysis of anandamide and eicosapentaenoic acid ethanolamide in mouse splenocytes. Biochemistry (Mosc) 65:615-619
14. Brindley DN (2004) Lipid phosphate phosphatases and related proteins: Signaling functions in development, cell division, and cancer. J Cell Biochem 92:900-912
15. CadasH, Gaillet S, BeltramoMet al. (1996a) Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. J Neurosci 16:3934-3942
16. Cadas H, Schinelli S, Piomelli D (1996b) Membrane localization of N-acylphosphatidylethanolamine in central neurons: studies with exogenous phospholipases. J Lipid Mediat Cell Signal 14:63-70
17. Carrier EJ, Kearn CS, Barkmeier AJ et al. (2004) Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptordependent mechanism. Mol Pharmacol 65:999-1007
18. Chen P, Hu S, Yao J et al. (2005) Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium. Microvasc Res 69:28-35
19. Craib SJ, Ellington HC, Pertwee RG et al. (2001) A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus. Br J Pharmacol 134:30-37
20. Cravatt BF, Giang DK, Mayfield SP et al. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384:83-87
21. Dawson RMC, Clarke N, Quarles RH (1969) N-acylphosphatidylethanolamine, a phospholipid that is rapidly metabolized during the early germination of pea seeds. Biochem J 114:265-267
22. De Petrocellis L, Melck D, Ueda N et al. (1997) Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase. Biochem Biophys Res Commun 231:82-88
23. Devane WA, Hanus L, Breuer A et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949
24. Di Marzo V, Fontana A, Cadas H et al. (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372:686-691
25. Di Marzo V, Bisogno T, Sugiura T et al. (1998) The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal-and basophil-like cells: connections with anandamide. Biochem J 331:15-19
26. Diana MA, Marty A (2004) Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br J Pharmacol 142:9-19
27. Dinh TP, Carpenter D, Leslie FM et al. (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 99:10819-10824
28. Dinh TP, Kathuria S, Piomelli D (2004) RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. Mol Pharmacol 66:1260-1264
29. Duncan M, Thomas AD, Cluny NL et al. (2008) Distribution and function of monoacylglycerol lipase in the gastrointestinal tract. Am J Physiol-Gastrointest Liver Physiol 295:G1255-G1265
30. Edgemond WS, Hillard CJ, Falck JR et al. (1998) Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. Mol Pharmacol 54:180-188
31. Edwards DA, Kim J, Alger BE (2006) Multiple mechanisms of endocannabinoid response initiation in hippocampus. J Neurophysiol 95:67-75
32. Egertova M, Simon GM, Cravatt BF et al. (2008) Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: A new perspective on Nacylethanolamines as neural signaling molecules. J Comp Neurol 506:604-615
33. Egertová M, Giang DK, Cravatt BF et al. (1998) A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc R Soc Lond B Biol Sci 265:2081-2085
34. Fowler CJ (2007) The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action. Br J Pharmacol 152:594-601
35. Fowler CJ, Tiger G, Stenstrom A (1997) Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship. J Pharmacol Exp Ther 283:729-734
36. Fowler CJ, Janson U, Johnson RM et al. (1999) Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen. Arch Biochem Biophys 362:191-196
37. Fowler CJ, Holt S, Tiger G (2003) Acidic nonsteroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependent manner. J Enzyme Inhib Med Chem 18:55-58
38. Fu J, Kim J, Oveisi F et al. (2008) Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats. Am J Physiol Regul Integr Comp Physiol 295:R45-R50
39. Gerdeman GL, Lovinger DM (2003) Emerging roles for endocannabinoids in long-term synaptic plasticity. Br J Pharmacol 140(5):781-789
40. Ghafouri N, Tiger G, Razdan RK et al. (2004) Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. Br J Pharmacol 143:774-784
41. Gillett MP, Vieira EM, Dimenstein R (1993) The phospholipase activities present in preheparin mouse plasma are inhibited by antiserum to hepatic lipase. Int J Biochem 25:449-453
42. Gillum MP, Zhang D, Zhang XM et al. (2008) N-acylphosphatidylethanolamine, a gut-derived circulating factor induced by fat ingestion, inhibits food intake. Cell 135:813-824
43. Glass M, Hong JW, Sato TA et al. (2005) Misidentification of prostamides as prostaglandins. J Lipid Res 46:1364-1368
44. Gobbi G, Bambico FR, Mangieri R et al. (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci USA 102:18620-18625
45. Goding JW, Grobben B, Slegers H (2003) Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. Biochim Biophys Acta-Mol Basis Dis 1638:1-19
46. Goparaju SK, Ueda N, Yamaguchi H et al. (1998) Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett 422:69-73
47. Grazia Cascio M, Minassi A, Ligresti A et al. (2004) A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase. Biochem Biophys Res Commun 314:192-196
48. Hada T, Hagiya H, Suzuki H et al. (1994) Arachidonate 12-lipoxygenase of rat pineal glands: catalytic properties and primary structure deduced from its cDNA. Biochim Biophys Acta 1211:221-228
49. Hampson AJ, Hill WAG, Zanphillips M et al. (1995) Anandamide hydroxylation by brain lipoxygenase: metabolite structures and potencies at the cannabinoid receptor. Biochim Biophys Acta-Lip Lip Met 1259:173-179
50. Hansen HS, Lauritzen L, Strand AM et al. (1995) Glutamate stimulates the formation of Nacylphosphatidylethanolamine and N-acylethanolamine in cortical neurons in culture. Biochim Biophys Acta-Lip Lip Met 1258:303-308
51. Hanus L, Gopher A, Almog S et al. (1993) Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor. J Med Chem 36:3032-3034
52. Hashimotodani Y, Ohno-Shosaku T, Maejima T et al. (2008) Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocanabinoid release. Neuropharmacol 54:58-67
53. Higgs HN, Glomset JA (1994) Identification of a phosphatidic acid-preferring phospholipase A1 from bovine brain and testis. Proc Natl Acad Sci USA 91:9574-9578
54. Higgs HN, Han MH, Johnson GE et al. (1998) Cloning of a phosphatidic acid-preferring phospholipase A1 from bovine testis. J Biol Chem 273:5468-5477
55. 1b. J Biol Chem 278:49438-49447
56. Hirasawa K, Irvine RF, Dawson RMC (1981) The catabolism of phosphatidylinositol by an EDTA-insensitive phospholipase A1 and calcium-dependent phosphatidylinositol phosphodiesterase in rat brain. Eur J Biochem 120:53-58
57. Ho W-SV, Randall MD (2007) Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. Br J Pharmacol 150:641-651
58. Hohmann AG, Suplita RL, Bolton NM et al. (2005) An endocannabinoid mechanism for stressinduced analgesia. Nature 435:1108-1112
59. Hoover HS, Blankman JL, Niessen S et al. (2008) Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling. Bioorg Med Chem Lett 18:5838-5841
60. Hu SSJ, Bradshaw HB, Chen JSC et al. (2008) Prostaglandin E-2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkB activity. Br J Pharmacol 153:1538-1549
61. Inoue M, Okuyama H (1984) Phospholipase A1 acting on phosphatidic acid in porcine platelet membranes. J Biol Chem 259:5083-5086
62. Jaye M, Lynch KJ, Krawiec J et al. (1999) A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet 21:424-428
63. Jhaveri MD, Richardson D, Robinson I et al. (2008) Inhibition of fatty acid amide hydrolase and cycloxygenase-2 increases levels of endocannabinoids and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain. Neuropharmacol 55:85-93
64. Jimenez-Monreal AM, Villalain J, Aranda FJ et al. (1998) The phase behavior of aqueous dispersions of unsaturated mixtures of diacylglycerols and phospholipids. Biochim Biophys Acta 1373:209-219
65. 2+-independent phosphatidylethanolamine N-acyltransferase generating the anandamide precursor and its congeners. J Biol Chem 282:3614-3623
66. Karbarz MJ, Luo L, Chang L et al. (2009) Biochemical and biological properties of 4-(3-phenyl-[1, 2, 4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase. Anesth Analg 108:316-329
67. Kathuria S, Gaetani S, Fegley D et al. (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9:76-81
68. Kim J, Alger BE (2004) Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat Neurosci 7:697-698
69. Kim J, Isokawa M, Ledent C et al. (2002) Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J Neurosci 22:10182-10191
70. Kobayashi T, Kishimoto M, Okuyama H (1996) Phospholipases involved in lysophosphatidylinositol metabolism in rat brain. J Lipid Mediat Cell Signal 14:33-37
71. Kohno M, Hasegawa H, Inoue A et al. (2006) Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18. Biochem Biophys Res Commun 347:827-832
72. Koutek B, Prestwich GD, Howlett AC et al. (1994) Inhibitors of arachidonoyl ethanolamide hydrolysis. J Biol Chem 269:22937-22940
73. Kozak KR, Rowlinson SW, Marnett LJ (2000) Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J Biol Chem 275:33744-33749
74. Kozak KR, Crews BC, Ray JL et al. (2001) Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo. J Biol Chem 276:36993-36998
75. Kozak KR, Gupta RA, Moody JS et al. (2002) 15-lipoxygenase metabolism of 2-arachidonylglycerol: Generation of a PPARa agonist. J Biol Chem 277:23278-23286
76. Kreitzer AC, Regehr WG (2001) Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29:717-727
77. Kucera GL, Sisson PJ, Thomas MJ et al. (1988) On the substrate specificity of rat liver phospholipase A1. J Biol Chem 263:1920-1928
78. Lee MW, Kraemer FB, Severson DL (1995) Characterization of a partially purified diacylglycerol lipase from bovine aorta. Biochim Biophys Acta 1254:311-318
79. Leung D, Saghatelian A, Simon GM et al. (2006) Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. Biochemistry 45:4720-4726
80. Lichtman AH, Hawkins EG, Griffin G et al. (2002) Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. J Pharmacol Exp Ther 302:73-79
81. Liu Q, Tonai T, Ueda N (2002) Activation of N-acylethanolamine-releasing phospholipase D by polyamines. Chem Phys Lipids 115:77-84
82. Liu J, Wang L, Harvey-White J et al. (2008) Multiple pathways involved in the biosynthesis of anandamide. Neuropharmacol 54:1-7
83. Long JZ, Li W, Booker L et al. (2009) Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol 5:37-44
84. Makara JK, Mor M, Fegley D et al. (2005) Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus. Nat Neurosci 8:1139-1141
85. Makara JK, Mor M, Fegley D et al. (2007) Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus. Nat Neurosci 10(1):134
86. Millns PJ, Chapman V, Kendall DA (2001) Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones. Br J Pharmacol 132:969-971
87. Moise AM, Eisenstein SA, Astarita G et al. (2008) An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters. Psychopharmacol 200:333-346
88. Moody JS, Kozak KR, Ji C et al. (2001) Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase. Biochemistry 40:861-866
89. Mulder AM, Cravatt BF (2006) Endocannabinoid metabolism in the absence of fatty acid amide hydrolase (FAAH): discovery of phosphorylcholine derivatives of N-acyl ethanolamines. Biochemistry 45:11267-11277
90. Nakane S, Oka S, Arai S et al. (2002) 2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acidcontaining lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoylsn-glycerol, a cannabinoid receptor ligand, in rat brain. Arch Biochem Biophys 402:51-58
91. Natarajan V, Reddy PV, Schmid PC et al. (1982) N-Acylation of ethanolamine phospholipids in canine myocardium. Biochim Biophys Acta 712:342-355
92. Natarajan V, Schmid PC, Reddy PV et al. (1984) Catabolism of N-acylethanolamine phospholipids by dog brain preparations. J Neurochem 42:1613-1619
93. Niforatos W, Zhang X-F, Lake MR et al. (2007) Activation of TRPA1 channels by the fatty acid amide hydrolase inhibitor 3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate (URB597). Mol Pharmacol 71:1209-1216
94. Nishiyama M, Watanabe T, Ueda N et al. (1993) Arachidonate 12-lipoxygenase is localized in neurons, glial cells, and endothelial cells of the canine brain. J Histochem Cytochem 41:111-117
95. Oka S, Tsuchie A, Tokumura A et al. (2003) Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species. J Neurochem 85:1374-1381
96. Oka S, Arai S, Waku K et al. (2007a) Depolarization-induced rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain synaptosomes. J Biochem 141:687-697
97. Oka S, Nakajima K, Yamashita A et al. (2007b) Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem Biophys Res Commun 362:928-934
98. Oka S, Toshida T, Maruyama K et al. (2009) 2-Arachidonoyl-sn-glycero-3-phosphoinositol: A Possible Natural Ligand for GPR55. J Biochem 145:13-20
99. Okamoto Y, Morishita J, Tsuboi K et al. (2004) Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem 279:5298-5305
100. Overton HA, Babbs AJ, Doel SM et al. (2006) Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab 3:167-175
101. 2Areceptor activation induces 2-arachidonoylglycerol release through a phospholipase C-dependent mechanism. J Neurochem 99:1164-1175
102. Patsos HA, Hicks DJ, Dobson RR et al. (2005) The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase-2. Gut 54:1741-1750
103. Petersen G, Hansen HS (1999) N-acylphosphatidylethanolamine-hydrolysing phospholipase D lacks the ability to transphosphatidylate. FEBS Lett 455:41-44
104. Reddy PV, Natarajan V, Schmid PC et al. (1983) N-Acylation of dog heart ethanolamine phospholipids by transacylase activity. Biochim Biophys Acta-Lip Lip Met 750:472-480
105. Rindlisbacher B, Reist M, Zahler P (1987) Diacylglycerol breakdown in plasma membranes of bovine chromaffin cells is a two-step mechanism mediated by a diacylglycerol lipase and a monoacylglycerol lipase. Biochim Biophys Acta 905:349-357
106. Rockwell CE, Raman P, Kaplan BLF et al. (2008) A COX-2 metabolite of the endogenous cannabinoid, 2-arachidonyl glycerol, mediates suppression of IL-2 secretion in activated Jurkat T cells. Biochem Pharmacol 76:353-361
107. Russo R, LoVerme J, La Rana G et al. (2007) The fatty-acid amide hydrolase inhibitor URB597 (cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice. J Pharmacol Exp Ther 322:236-242
108. Saario SM, Savinainen JR, Laitinen JT et al. (2004) Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Biochem Pharmacol 67:1381-1387
109. Sakagami H, Aoki J, Natori Y et al. (2005) Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/ phosphodiesterase family. J Biol Chem 280:23084-23093
110. Sang N, Zhang J, Chen C (2006) PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons. J Physiol 572:735-745
111. Sang N, Zhang J, Chen C (2007) COX-2 oxidative metabolite of endocannabinoid 2-AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity. J Neurochem 102:1966-1977
112. Sarmad S, Patel A, Barrett DA et al. (2008) Calcium-independent formation of endocannabinoids in rat brain slices. Proceedings of the British Pharmacological Society, p 111P
113. Sato T, Aoki J, Nagai Y et al. (1997) Serine phospholipid-specific phospholipase A that is secreted from activated platelets. A new member of the lipase family. J Biol Chem 272:2192-2198
114. Schmid PC, Reddy PV, Natarajan V et al. (1983) Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type. J Biol Chem 258:9302-9306
115. Simon GM, Cravatt BF (2006) Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for a/b hydrolase 4 in this pathway. J Biol Chem 281:26465-26472
116. Simon GM, Cravatt BF (2008) Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-n-acyl ethanolamine precursors in mouse brain. J Biol Chem 283:9341-9349
117. Snider NT, Kornilov AM, Kent UM et al. (2007) Anandamide metabolism by human liver and kidney microsomal cytochrome P450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. J Pharmacol Exp Ther 321:590-597
118. Snider NT, Sikora MJ, Sridar C et al. (2008) The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6. J Pharmacol Exp Ther 327:538-545
119. Stark K, Dostalek M, Guengerich FP (2008) Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide. FEBS J 275:3706-3717
120. Stella N, Piomelli D (2001) Receptor-dependent formation of endogenous cannabinoids in cortical neurons. Eur J Pharmacol 425:189-196
121. Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates longterm potentiation. Nature 388:773-778
122. Sugiura T, Waku K (2000) 2-Arachidonoylglycerol and the cannabinoid receptors. pp. 89-106.
123. Sugiura T, Waku K (2002) Cannabinoid receptors and their endogenous ligands. J Biochem 132:7-12
124. Sugiura T, Kondo S, Sukagawa A et al. (1996) Transacylase-mediated and phosphodiesterasemediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid receptor ligand, in rat brain microsomes: comparison with synthesis from free arachidonic acid and ethanolamine. Eur J Biochem 240:53-62
125. Sugiura T, Kodaka T, Kondo S et al. (1997) Is the cannabinoid CB1 receptor a 2-arachidonoylglycerol receptor? Structural requirements for triggering a Ca2+ transient in NG108-15 cells. J Biochem (Tokyo) 122:890-895
126. Sugiura T, Kodaka T, Nakane S et al. (1999) Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol ether-linked analogues, and related compounds. J Biol Chem 274:2794-2801
127. Suh PG, Park JI, Manzoli L et al. (2008) Multiple roles of phosphoinositide-specific phospholipase C isozymes. BMB Rep 41(6):415-434
128. 2and lysophospholipase D. Biochem J 380:749-756
129. Sun YX, Tsuboi K, Zhao LY et al. (2005) Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages. Biochim Biophys Acta 1736:211-220
130. Sutherland CA, Amin D (1982) Relative activities of rat and dog platelet phospholipase A2 and diglyceride lipase. Selective inhibition of diglyceride lipase by RHC 80267. J Biol Chem 257:14006-14010
131. Szabo B, Urbanski MJ, Bisogno T et al. (2006) Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. J Physiol 577:263-280
132. Tian XY, Guo JX, Yao FM et al. (2005) The conformation, location, and dynamic properties of the endocannabinoid ligand anandamide in a membrane bilayer. J Biol Chem 280:29788-29795
133. Tornqvist H, Belfrage P (1976) Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue. J Biol Chem 251:813-819
134. Tsou K, Nogueron MI, Muthian S et al. (1998) Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neurosci Lett 254:137-140
135. Tsuboi K, Hilligsmann C, Vandevoorde S et al. (2004) N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase. Biochem J 379:99-106
136. Tsuboi K, Sun YX, Okamoto Y et al. (2005) Molecular characterization of N-acylethanolaminehydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. J Biol Chem 280:11082-11092
137. Tsutsumi T, Kobayashi T, Ueda H et al. (1994) Lysophosphoinositide-specific phospholipase C in rat brain synaptic plasma membranes. Neurochem Res 19:399-406
138. Tsutsumi T, Kobayashi T, Miyashita M et al. (1995) A lysophosphoinositide-specific phospholipase C distinct from other phospholipase C families in rat brain. Arch Biochem Biophys 317:331-336
139. Ueda H, Kobayashi T, Kishimoto M et al. (1993a) A possible pathway of phosphoinositide metabolism through EDTA-insensitive phospholipase A1 followed by lysophosphoinositidespecific phospholipase C in rat brain. J Neurochem 61:1874-1881
140. 1highly specific for phosphatidylinositol in bovine brain. Biochem Biophys Res Commun 195:1272-1279
141. Ueda N, Yamamoto K, Yamamoto S et al. (1995) Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist. Biochim Biophys Acta-Lip Lip Met 1254:127-134
142. Ueda N, Yamanaka K, Terasawa Y et al. (1999) An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors. FEBS Lett 454:267-270
143. 2+influx via TRPV1 channels. EMBO J 24:3026-3037
144. Van Zadelhoff G, Veldink GA, Vliegenthart JFG (1998) With anandamide as substrate plant 5-lipoxygenases behave like 11-lipoxygenases. Biochem Biophys Res Commun 248:33-38
145. Vandevoorde S, Saha B, Mahadevan A et al. (2005) Influence of the degree of unsaturation of the acyl side chain upon the interaction of analogues of 1-arachidonoylglycerol with monoacylglycerol lipase and fatty acid amide hydrolase. Biochem Biophys Res Commun 337:104-109
146. Vandevoorde S, Jonsson KO, Labar G et al. (2007) Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro. Br J Pharmacol 150:186-191
147. Varma N, Carlson GC, Ledent C et al. (2001) Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J Neurosci 21:RC133
148. Veldhuis WB, van der Stelt M, Wadman MW et al. (2003) Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: Role of vanilloid receptors and lipoxygenases. J Neurosci 23:4127-4133
149. Vellani V, Petrosino S, De Petrocellis L et al. (2008) Functional lipidomics. Calcium-independent activation of endocannabinoid/endovanilloid lipid signalling in sensory neurons by protein kinases C and A and thrombin. Neuropharmacol 55:1274-1279
150. Vila A, Rosengarth A, Piomelli D et al. (2007) Hydrolysis of prostaglandin glycerol esters by the endocannabinoid-hydrolyzing enzymes, monoacylglycerol lipase and fatty acid amide hydrolase. Biochemistry 46:9578-9585
151. Walter L, Dinh T, Stella N (2004) ATP induces a rapid and pronounced increase in 2-arachidonoylglycerol production by astrocytes, a response limited by monoacylglycerol lipase. J Neurosci 24:8068-8074
152. Wang J, Okamoto Y, Morishita J et al. (2006) Functional analysis of the purified anandamidegenerating phospholipase D as a member of the metallo-b-lactamase family. J Biol Chem 281:12325-12335
153. Wang J, Okamoto Y, Tsuboi K et al. (2008a) The stimulatory effect of phosphatidylethanolamine on N-acylphosphatidylethanolamine-hydrolyzing phospholipase D (NAPE-PLD). Neuropharmacol 54:8-15
154. Wang J, Zhao LY, Uyama T et al. (2008b) Amino acid residues crucial in pH regulation and proteolytic activation of N-acylethanolamine-hydrolyzing acid amidase. Biochim Biophys Acta 1781:710-717
155. Wei BQ, Mikkelsen TS, McKinney MK et al. (2006) A second fatty acid amide hydrolase with variable distribution among placental mammals. J Biol Chem 281:36569-36578
156. Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410:588-592
157. Wilson RI, Kunos G, Nicoll RA (2001) Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31:453-462
158. Woodward DF, Carling RW, Cornell CL et al. (2008) The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. Phamacol Ther 120(1):71-80
159. Yoshida T, Hashimoto K, Zimmer A et al. (2002) The cannabinoid CB1 receptor mediates retrograde signals for depolarization-induced suppression of inhibition in cerebellar Purkinje cells. J Neurosci 22:1690-1697
160. 2ethanolamide from anandamide by cyclooxygenase-2. J Biol Chem 272:21181-21186
161. Zhang D, Saraf A, Kolasa T et al. (2007) Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets. Neuropharmacol 52:1095-1105
162. Zheng B, Chen D, Farquhar MG (2000) MIR16, a putative membrane glycerophosphodiester phosphodiesterase, interacts with RGS16. Proc Natl Acad Sci USA 97:3999-4004
163. Zheng B, Berrie CP, Corda D et al. (2003) GDE1/MIR16 is a glycerophosphoinositol phosphodiesterase regulated by stimulation of G protein-coupled receptors. Proc Natl Acad Sci USA 100:1745-1750